- Home
- ALV vs LNTH Comparison
ALV vs LNTH Comparison
Compare ALV & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALV
- LNTH
- Stock Information
- Founded
- ALV 1953
- LNTH 1956
- Country
- ALV Sweden
- LNTH United States
- Employees
- ALV N/A
- LNTH N/A
- Industry
- ALV Auto Parts:O.E.M.
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ALV Consumer Discretionary
- LNTH Health Care
- Exchange
- ALV Nasdaq
- LNTH Nasdaq
- Market Cap
- ALV 7.7B
- LNTH 7.2B
- IPO Year
- ALV 1997
- LNTH 2015
- Fundamental
- Price
- ALV $98.90
- LNTH $90.52
- Analyst Decision
- ALV Buy
- LNTH Strong Buy
- Analyst Count
- ALV 13
- LNTH 7
- Target Price
- ALV $124.08
- LNTH $121.86
- AVG Volume (30 Days)
- ALV 719.5K
- LNTH 1.6M
- Earning Date
- ALV 10-18-2024
- LNTH 11-06-2024
- Dividend Yield
- ALV 2.75%
- LNTH N/A
- EPS Growth
- ALV 59.39
- LNTH 304.57
- EPS
- ALV 7.72
- LNTH 6.02
- Revenue
- ALV $10,525,000,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ALV $1.14
- LNTH $19.56
- Revenue Next Year
- ALV $4.49
- LNTH $6.32
- P/E Ratio
- ALV $12.81
- LNTH $15.03
- Revenue Growth
- ALV 4.63
- LNTH 24.15
- 52 Week Low
- ALV $89.51
- LNTH $50.20
- 52 Week High
- ALV $129.38
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ALV 54.49
- LNTH 45.56
- Support Level
- ALV $94.84
- LNTH $75.00
- Resistance Level
- ALV $102.07
- LNTH $118.21
- Average True Range (ATR)
- ALV 2.35
- LNTH 5.13
- MACD
- ALV -0.11
- LNTH 0.13
- Stochastic Oscillator
- ALV 60.86
- LNTH 38.71
About ALV Autoliv Inc.
Autoliv is the global leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.